Regeneron Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (2)

Latest Articles

About This Stock More About This Stock
4 Top Biotech Stocks To Buy For 2022
Article By: Rick Ristov
Wednesday, December 22, 2021 7:23 AM EST
Regulatory approvals from FDA and EUA and growing investment and policy support from governments worldwide forecast a bright outlook for the biotech industry in the long run.
In this article: REGN, BIIB, EXEL, UTHR Also: FBT, SPY
Read
Hot Bargains In Big Biotech
Article By: Bret Jensen
Tuesday, November 18, 2014 12:00 PM EST
It has been an eventful year in the big pharma and biotech space, and a lot is happening in this space that biotech investors should take note of.
In this article: AGN, AVNR, REGN, AMGN, BIIB, CELG, GILD, ABBV
Read
Rayno Life Science Small Cap Picks: CLDX, PACB, FMI…Update-1
Article By: Rod Raynovich
Monday, November 17, 2014 12:00 PM EST
Recent small cap picks.
In this article: ALXN, CLDX, GHDX, ILMN, REGN, SGEN, ALKS, GILD, PACB, KPTI, FMI, FCSC
Read
Insider Trading Report Edition 230: Notable Buys And Sales
Article By: Asif Suria
Sunday, November 16, 2014 4:19 PM EST
Insider buying decreased last week with insiders buying $73.83 million of stock compared to $90.85 million in the week prior. Selling also decreased with insiders selling $1.67 billion of stock last week compared to $2.18 billion in the week prior.
In this article: CHK, HAS, LF, NMFC, P, SCHW, X, TRUE, PSEC, REGN, FNFG, MDRX, MEMP, NOW, RCPT, TPUB
Read
Bullish Conviction Returns, But Market Likely To Consolidate Its V-bottom
Article By: Sabrient Systems
Monday, October 27, 2014 9:14 AM EST
Bulls showed renewed backbone last week and drew a line in the sand for the bears, buying with gusto into weakness as I suggested they would.
In this article: COP, CVX, JPM, SLG, XOM, REGN, GILD, PBE, SPY, XLK, FB, VIX, KBWI
Read
Corporate Vs. Non-Corporate Partnerships, Joint Ventures, Merger And Acquisitions, And MannKind’s Affairs
Article By: Retail Investor 360
Sunday, October 26, 2014 6:13 PM EST
The market has been speculating as to whether the MannKind-Sanofi partnership will lead to a full-blown merger and acquisition.
In this article: SNY, MNKD, REGN
Read

Latest Tweets for $REGN

No tweets yet!

PARTNER HEADLINES